KT:NYSEKT Corporation Analysis
Data as of 2026-08-25 - not real-time
$19.03
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
At $19.03, KT Corporation shows no decisive moving-average alignment, leaving the trend neutral. Over a rolling month the price has gained 9.7%. With RSI at 58.1 the momentum picture is neutral, alongside a bullish MACD signal. The recent range runs from support at $17.94 up to resistance at $19.37.
Valuation screens as undervalued: a P/E of 9.9 sits below the sector average of 16.3. Sell-side targets cluster 15.3% above the current quote. Revenue is contracting at 10.1% on a 4.7% profit margin. The 4.30% dividend yield looks covered by current payout levels.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 20.1%, a beta of 0.46 and a maximum drawdown of 29.7%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on buy — conviction 6 out of 10.
Valuation screens as undervalued: a P/E of 9.9 sits below the sector average of 16.3. Sell-side targets cluster 15.3% above the current quote. Revenue is contracting at 10.1% on a 4.7% profit margin. The 4.30% dividend yield looks covered by current payout levels.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 20.1%, a beta of 0.46 and a maximum drawdown of 29.7%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons line up on buy — conviction 6 out of 10.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 4/10
Key Factors
- Trading below the 200-day average of 19.81
- MACD momentum is positive
- 30-day price change of +9.7%
Medium Term
1–3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 9.9 versus sector average of 16.3
- Trading below the 200-day average of 19.81
- Analyst targets imply +15.3% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- P/E of 9.9 versus sector average of 16.3
- Analyst targets imply +15.3% versus the current price
- Revenue contracting at -10.1%
Key Metrics & Analysis
Financial Health
Revenue Growth-10.10%
Profit Margin4.72%
P/E Ratio9.9
ROE7.15%
ROA2.69%
Debt/Equity61.74
P/B Ratio0.7
Op. Cash Flow$4427.1B
Free Cash Flow$857.8B
Industry P/E16.3
Technical Analysis
TrendNeutral
RSI58.1
Support$17.94
Resistance$19.37
MA 20$18.64
MA 50$18.23
MA 200$19.81
MACDBullish
VolumeDecreasing
Fear & Greed Index93.32
Valuation
Fair Value$6,785.44
Target Price$21.94
Upside/Downside15.32%
GradeUndervalued
TypeValue
Dividend Yield4.30%
Risk Assessment
Beta0.46
Volatility20.14%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.